Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “H1N1 Flu”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01001169
What this trial is testing

Safety and Immunogenocity Study of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Japanese Children

Who this might be right for
Influenza
GlaxoSmithKline 60
Testing effectiveness (Phase 2)WithdrawnNCT00964951
What this trial is testing

CSL H1N1 Influenza Vaccine Administered at Different Dose Levels With and Without AS03 Adjuvant in Healthy Adult and Elderly Populations

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID)
Early research (Phase 1)Study completedNCT01177202
What this trial is testing

Study of the Safety and Immunogenicity of H1N1 Vaccine

Who this might be right for
H1N1 Flu
Fraunhofer, Center for Molecular Biotechnology 80
Not applicableStudy completedNCT05797103
What this trial is testing

The Research of Novel Electrolyzed Water Spray to Eradicate Bacteria E-coli and an Attenuated Human Flu Virus

Who this might be right for
Bacterial GrowthNovel Influenza A (H1N1)
Dove Medical Press Ltd 20
Early research (Phase 1)Study completedNCT00943358
What this trial is testing

Safety and Immunogenicity of A/H1N1v Vaccines in Healthy Adults

Who this might be right for
Influenza
University Hospitals, Leicester 175
Post-approval studies (Phase 4)Study completedNCT00956111
What this trial is testing

A Clinical Trial With Influenza A/H1N1 Vaccines

Who this might be right for
Influenza
Sinovac Biotech Co., Ltd 1,614
Testing effectiveness (Phase 2)Study completedNCT01971255
What this trial is testing

Evaluation of Anti-Hemagglutinin (Anti-HA) Antibodies as Protection From the Flu in Healthy People

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 74
Not applicableUnknownNCT01046227
What this trial is testing

Antibody Titer Analysis After H1N1 Vaccination in Pediatric Haemato-oncology Patients

Who this might be right for
Serology AnalysisNovel H1N1 Influenza VaccinationPediatric Haemato-oncology Patients
National Taiwan University Hospital 50
Testing effectiveness (Phase 2)UnknownNCT01055990
What this trial is testing

Basic and Clinical Research on Applying Blood Fix to Treat Critical H1N1 Patients

Who this might be right for
Virus DiseasesRespiratory Tract DiseasesRespiratory Tract Infections+2 more
Shanghai Public Health Clinical Center 7
Testing effectiveness (Phase 2)Study completedNCT01008813
What this trial is testing

Clinical Trial to Evaluate the Immunogenicity and Safety of an Adjuvanted A(H1N1)v Influenza Vaccine and a Non-adjuvanted A(H1N1)v Influenza Vaccine in HIV-infected Patients (ANRS 151 Hifluvac)

Who this might be right for
HIV Infections
French National Agency for Research on AIDS and Viral Hepatitis 306
Early research (Phase 1)Study completedNCT01059617
What this trial is testing

Safety and Immune Response of Candidate H1N1 Influenza Vaccine GSK2340274A Following Seasonal Influenza Vaccination in Adults

Who this might be right for
Influenza
GlaxoSmithKline 133
Not applicableStudy completedNCT01394640
What this trial is testing

Immunologic Response After Pandemic Influenza A (H1N1) Vaccine in Onco- Hematologic Patients

Who this might be right for
LymphomaMultiple MyelomaMyeloproliferative Disease
Paolo Corradini 124
Testing effectiveness (Phase 2)Looking for participantsNCT07215858
What this trial is testing

BPL-1357 Against H1N1 Influenza Virus Challenge

Who this might be right for
InfluenzaHuman
National Institute of Allergy and Infectious Diseases (NIAID) 129
Post-approval studies (Phase 4)Study completedNCT02143882
What this trial is testing

A Phase III/IV Open-label Study of the Immunogenicity and Safety of a Single Dose of a Live Attenuated Influenza Vaccine (LAIV) (FluenzTM) for Each of Three Successive Years in Children naïve to, or in Previous Receipt of the AS03B Adjuvanted H1N1 (2009) Influenza Vaccine (Pandemrix ™).

Who this might be right for
Live Attenuated Influenza Vaccine
Public Health England 300
Testing effectiveness (Phase 2)WithdrawnNCT00989274
What this trial is testing

Clinical Trial to Evaluate the Immunogenicity and Safety of the Vaccine Against Influenza A/H1N1

Who this might be right for
Influenza
Instituto Nacional de Salud Publica, Mexico
Not applicableStudy completedNCT01289418
What this trial is testing

Surveillance for Adverse Events Following Pandemic H1N1 Immunization

Who this might be right for
Novel Influenza A/H1N1
PHAC/CIHR Influenza Research Network 6,525
Testing effectiveness (Phase 2)Ended earlyNCT01003418
What this trial is testing

Study to Evaluate Safety and Immunogenicity of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Children

Who this might be right for
Influenza
GlaxoSmithKline 8
Not applicableStudy completedNCT01056354
What this trial is testing

Respiratory Virus Outpatient Study (FLU 002 Plus)

Who this might be right for
Influenza and Other Novel Respiratory Viruses
University of Minnesota 11,719
Not applicableStudy completedNCT05572450
What this trial is testing

Dose, Safety, and Pathogenicity of a New Influenza H1N1 Challenge Strain

Who this might be right for
Influenza A H1N1
Hvivo 70
Early research (Phase 1)Study completedNCT01498718
What this trial is testing

Seasonal Influenza DNA Vaccine Prime With Trivalent Inactivated Vaccine (TIV) Boost Compared to TIV Alone

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 131
Next Page